INTEGRATED FILING — Other than Banks



General information about company

Scrip code 000000
NSE Symbol MHHL
MSEI Symbol NOTLISTED
ISIN INE450S01011
Name of Company MOHINI HEALTH & HYGIENE LIMITED
Type of company SME
Class of security Equity
Date of start of financial year 01-Apr-2024
Date of end of financial year 31-Mar-2025
Date of board meeting when results were approved 29-May-2025
Date on which prior intimation of the meeting for considering financial results was informed to the exchange 22-May-2025
Description of presentation currency INR (in Actuals)
Reporting Type Half Yearly
Reporting Quarter Yearly
Nature of report standalone or consolidated Standalone
Whether results are audited or unaudited for the quarter ended Audited
Whether results are audited or unaudited for the Year to date for current period ended/year ended Audited
Segment Reporting Single segment
Description of single segment manufacturing
Start date and time of board meeting 29-May-2025   16:40:00
End date and time of board meeting 29-May-2025   19:15:00
Whether cash flow statement is applicable on company Yes
Type of cash flow statement Cash Flow Indirect
Declaration of unmodified opinion or statement on impact of audit qualification Statement on impact of audit qualification
Whether the company has any related party? Yes
Whether the company has entered into any Related Party transaction during the selected half year for which it wants to submit disclosure? Yes
(I) We declare that the acceptance of fixed deposits by the bans/Non-Banking Finance Company are at the terms uniformly applicable/offered to all shareholders/public NA
(II) We declare that the scheduled commercial bank, as per RBI circular RBI/DBR/2015-16/19 dated March 03, 2016, has allowed additional interest of one per cent per annum, over and above the rate of interest mentioned in the schedule of interest rates on savings or a term deposits of banks staff and their exclusive associations as well as on deposits of Chairman, Chairman & Managing Director, Executive Director or such other Executives appointed for a fixed tenure. NA
(III) Whether the company is a high value debt listed entity according to regulation 15 (1A)? No
(a) If answer to above question is Yes, whether complying with proviso to regulation 23 (9), i.e., submitting RPT disclosures on the day of results publication?
(b) If answer to above question is No, please explain the reason for not complying.
Whether the updated Related Party Transactions (RPT) Policy (in compliance with Reg. 23 of SEBI LODR) has been uploaded on the website of the Company? Yes
Latest Date on which RPT policy is updated 2025-05-29
Indicate Company website link for updated RPT policy of the Company https://mohinihealthandhygiene.com/investor_relations/policies-programme/
Whether statement on deviation or variation for proceeds of public issue, rights issue, preferential issue, qualified institutions placement etc. is applicable to the company for the current quarter? No
No. of times funds raised during the quarter
Whether the disclosure for the Default on Loans and Debt Securities is applicable to the entity? No
There is no defaults on loans. nThe Company does not have debt securities.


Financial Results — Other than Bank
Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-Oct-2024 01-Apr-2024
B Date of end of reporting period 31-Mar-2025 31-Mar-2025
C Whether results are audited or unaudited Audited Audited
D Nature of report standalone or consolidated Standalone Standalone
Part I Blue color marked fields are non-mandatory. For Consolidated Results, if the company has no figures for 3 months / 6 months ended, in such case zero shall be inserted in the said column.
1 Revenue From Operations
Revenue from operations 763331000 1677714000
Other income 95038000 108939000
Total Income 858369000 1786653000
2 Expenses
(a) Cost of materials consumed 644867000 1297164000
(b) Purchases of stock-in-trade 0 0
(c) Changes in inventories of finished goods, work-in-progress and stock-in-trade -99100000 -142174000
(d) Employee benefit expense 28935000 62403000
(e) Finance costs 16806000 31651000
(f) Depreciation and amortisation expense 25066000 47273000
(g) Other Expenses
1 Direct Manufacturing Cost 51643000 104851000
2 Export Selling Expenses 77191000 156605000
3 Other Expenses 32260000 79507000
Total other expenses 161094000 340963000
Total expenses 777668000 1637280000
3 Profit before exceptional and extraordinary items and tax 80701000 149373000
4 Exceptional items 0 0
5 Profit before extraordinary items and tax 80701000 149373000
6 Extraordinary items -63722000 -63722000
7 Profit before tax 16979000 85651000
8 Tax Expense
Current tax 10323000 29107000
Deferred tax -4424000 -2762000
Total tax expenses 5899000 26345000
9 Net Profit Loss for the period from continuing operations 11080000 59306000
10 Profit (loss) from discontinuing operations before tax 0 0
11 Tax expense of discontinuing operations 0 0
12 Net profit (loss) from discontinuing operation after tax 0 0
13 Profit (loss) for period before minority interest 11080000 59306000
14 Share of profit (loss) of associates
15 Profit (loss) of minority interest
16 Net profit (Loss) for the period 11080000 59306000
17 Details of equity share capital
Paid-up equity share capital 182359000 182359000
Face value of equity share capital 10 10
18 Reserves excluding revaluation reserve 872331000
19 Earnings per equity share
Basic earnings (loss) per share from continuing and discontinued operations 0.61 3.25
Diluted earnings (loss) per share from continuing and discontinued operations 0.61 3.25
20 Debt equity ratio 0.0 0.0
21 Debt service coverage ratio 0.0 0.0
22 Interest service coverage ratio 0.0 0.0
23 Disclosure of notes on financial results Textual Information(1)


Text Block
Textual Information(1) 1) The audited standalone financial results which are published in accordance with Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 as amended (“the Regulation’Regulation”) have been reviewed and recommended by the Audit Committee and were approved & taken on record by the Board of Directors at their respective meeting held on 29th May, 2025. The Statutory Auditors have expressed modified opinion on these results. 2) The Financial Results have been prepared in accordance with the Accounting Standards as notified under Section 133 of the Companies Act, 2013 read with relevant rules issued there under and other accounting principles generally accepted in India as amended from time to time. 3) Segment reporting as required under AS-17 is not applicable, as 100% revenue comes from a single segment of manufacturing. 4) Figures for the previous period have been regrouped/reclassified wherever necessary, to confirm to the figures of the current period's classification. 5) The Company has recognised notional loss of Rs. 12.53 lakhs and Rs 39.05 lakhs on open forward contracts in the audited standalone financial results for the year ended 31st March 2025 and 31st March 2024 respectively. 6) During the year ended 31st March, 2025 the company has recognised amortization of leasehold land relating to previous years amounting to Rs. 18.74 lakhs shown as Prior period Item on the face of Profit & Loss. 7) On 24th May 2021, a major fire broke out at the manufacturing facility of the company located at Plot No.109, Sector 3, Pithampur Industrial Area, District Dhar (MP) - 454774. There was no harm to human lives or injuries. The company suffered substantial loss to Building, Plant & Machinery and Inventory on account of fire. We have submitted our claim with the Surveyor of the Insurance Company and the Company has booked insurance claim receivable amounting to Rs. 2,503.73 lakhs as at 31 March, 2024 which is still under process with the insurance company. During the F.Y. 2024-25 the company has written off insurance claim amounting to Rs. 618.48 lakhs shown as Extraordinary Item on the face of Profit & Loss. Due to fire incident, operations of the Bleaching unit were disrupted during the period from 24.05.2021 to 02.08.2021. Now the routine operations have been restored and plant has achieved optimum capacity utilization. 8) The figures for the last half year are balancing figures between audited figures in respect of full financial year & published year to date figures upto the first half year of the respective financial year.


Remarks
20 Debt equity ratio half year 01-10-2025 to 31.03.2025-0.33 nyearly 01.04.2025 to 31.03.2025-0.33
21 Debt service coverage ratio half year-0.68 nyearly-1.53
22 Interest service coverage ratio half year-2.01 nYearly-3.71


Cash flow statement — indirect
A Date of start of reporting period 01-Apr-2024
B Date of end of reporting period 31-Mar-2025
C Whether results are audited or unaudited Audited
D Nature of report standalone or consolidated Standalone
1 Statement of cash flows
Cash flows from used in operating activities
Profit before extraordinary items and tax 149373000
2 Adjustments for reconcile profit (loss)
Adjustments to profit (loss)
Adjustments for finance costs 31651000
Adjustments for depreciation and amortisation expense 47273000
Adjustments for impairment loss reversal of impairment loss recognised in profit or loss 0
Adjustments for unrealised foreign exchange losses gains 0
Adjustments for dividend income 0
Adjustments for share-based payments 0
Other adjustments for which cash effects are investing or financing cash flow 4690000
Other adjustments to reconcile profit (loss) 0
Other adjustments for non-cash items 0
Share of profit and loss from partnership firm or association of persons or limited liability partnerships 0
Total adjustments to profit (loss) 83614000
3 Adjustments for working capital
Adjustments for decrease (increase) in inventories -146336000
Adjustments for decrease (increase) in trade receivables 183039000
Adjustments for decrease (increase) in other current assets -32580000
Adjustments for increase (decrease) in trade payables 53103000
Adjustments for increase (decrease) in other current liabilities 50675000
Adjustments for provisions 3864000
Total adjustments for working capital 111765000
Total adjustments for reconcile profit (loss) 195379000
Net cash flows from (used in) operations 344752000
Dividends received -38000
Interest paid 0
Interest received -2377000
Income taxes paid (refund) 29107000
Other inflows (outflows) of cash -11475000
Net cash flows from (used in) operating activities before extraordinary items 301755000
Proceeds from extraordinary items 0
Payment for extraordinary items 0
Net cash flows from (used in) operating activities 301755000
4 Cash flows from used in investing activities
Cash flows from losing control of subsidiaries or other businesses 0
Cash flows used in obtaining control of subsidiaries or other businesses 0
Other cash receipts from sales of equity or debt instruments of other entities 0
Other cash payments to acquire equity or debt instruments of other entities 6909000
Other cash receipts from sales of interests in joint ventures 0
Other cash payments to acquire interests in joint ventures 0
Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships 0
Cash payment for investment in partnership firm or association of persons or limited liability partnerships 0
Proceeds from sales of property plant and equipment 0
Purchase of property plant and equipment 218134000
Proceeds from sales of intangible assets 0
Purchase of intangible assets 0
Cash advances and loans made to other parties 0
Cash receipts from repayment of advances and loans made to other parties -62469000
Cash payments for future contracts, forward contracts, option contracts and swap contracts 0
Cash receipts from future contracts, forward contracts, option contracts and swap contracts 0
Dividends received 38000
Interest received 2377000
Income taxes paid (refund) 0
Other inflows (outflows) of cash -4690000
Proceeds from government grants 0
Net cash flows from (used in) investing activities before extraordinary items -289787000
Proceeds from extraordinary items 0
Payment for extraordinary items 0
Net cash flows from (used in) investing activities -289787000
Cash flows from used in financing activities
Proceeds from issuing shares 0
Proceeds from issuing other equity instruments 0
Proceeds from issuing debentures notes bonds etc 0
Proceeds from borrowings 158350000
Repayments of borrowings 38339000
Dividends paid 9118000
Interest paid 31651000
Income taxes paid (refund) 0
Other inflows (outflows) of cash 0
Net cash flows from (used in) financing activities before extraordinary items 79242000
Proceeds from extraordinary items 0
Payment for extraordinary items 0
Net cash flows from (used in) financing activities 79242000
Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes 91210000
6 Effect of exchange rate changes on cash and cash equivalents
Effect of exchange rate changes on cash and cash equivalents 0
Net increase (decrease) in cash and cash equivalents 91210000
Cash and cash equivalents cash flow statement at beginning of period 49606000
Cash and cash equivalents cash flow statement at end of period 140816000


Statement of Asset and Liabilities
Particulars Year ended (dd-mm-yyyy)
Date of start of reporting period 01-Apr-2024
Date of end of reporting period 31-Mar-2025
Whether results are audited or unaudited Audited
Nature of report standalone or consolidated Standalone
Equity and liabilities
1 Shareholders' funds
Share capital 182359000
Reserves and surplus 872331000
Money received against share warrants 0
Total shareholders' funds 1054690000
2 Share application money pending allotment 0
3 Deferred government grants 0
4 Minority interest
5 Non-current liabilities
Long-term borrowings 17485000
Deferred tax liabilities (net) 42290000
Foreign currency monetary item translation difference liability account 0
Other long-term liabilities 0
Long-term provisions 6181000
Total non-current liabilities 65956000
6 Current liabilities
Short-term borrowings 327742000
Trade Payables
(A) Total outstanding dues of micro enterprises and small enterprises 323000
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises 92150000
Total Trade payable 92473000
Other current liabilities 87997000
Short-term provisions 50487000
Total current liabilities 558699000
Total equity and liabilities 1679345000
Assets
1 Non-current assets
i Property, Plant and Equipment and Intangible assets
Property, Plant and Equipment 371274000
Producing properties 0
Intangible assets 0
Preproducing properties 0
Property, Plant and Equipment capital work-in-progress 11948000
Intangible assets under development or work-in-progress 0
Total Property, Plant and Equipment and Intangible assets 383222000
ii Non-current investments 22563000
v Deferred tax assets (net) 0
vi Foreign currency monetary item translation difference asset account 0
vii Long-term loans and advances 0
viii Other non-current assets 21210000
Total non-current assets 426995000
Current assets
Current investments 0
Inventories 369304000
Trade receivables 179525000
Cash and cash equivalents 140816000
Bank balance other than cash and cash equivalents 0
Short-term loans and advances 96768000
Other current assets 465937000
Total current assets 1252350000
Total assets 1679345000
Disclosure of notes on assets and liabilities


Format for Reporting Segment wise Revenue, Results and Capital Employed along with the company results
Particulars 3 months/ 6 month ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period 01-Oct-2024 01-Apr-2024
Date of end of reporting period 31-Mar-2025 31-Mar-2025
Whether results are audited or unaudited Audited Audited
Nature of report standalone or consolidated Standalone Standalone
1 Segment Revenue (Income)
(net sale/income from each segment should be disclosed)
Total Segment Revenue
Less: Inter segment revenue
Revenue from operations
2 Segment Result
Profit (+) / Loss (-) before tax and interest from each segment
Total Profit before tax
i. Finance cost
ii. Other Unallocable Expenditure net off Unallocable income
Profit before tax
3 (Segment Asset - Segment Liabilities)
Segment Asset
Total Segment Asset
Un-allocable Assets
Net Segment Asset
4 Segment Liabilities
Segment Liabilities
Total Segment Liabilities
Un-allocable Liabilities
Net Segment Liabilities
Disclosure of notes on segments




Details of Impact of Audit Qualification
Whether results are audited or unaudited Audited
Declaration of unmodified opinion or statement on impact of audit qualification Statement on impact of audit qualification
Auditor's opinion Qualified opinion
Declaration pursuant to Regulation 33 (3) (d) of SEBI (LODR) Regulation, 2015: The company declares that its Statutory Auditor/s have issued an Audit Report with unmodified opinion for the period on Standalone results
Sr No. Audit firm's name Whether the firm holds a valid peer review certificate issued by Peer Review Board of ICAI Certificate valid upto
1 Mahesh C. Solanki & Co. Yes 30-Apr-2027


Financial details
Sr. Particulars Audited Figures (as reported before adjusting for qualifications) Adjusted Figures (audited figures after adjusting for qualifications)
1 Turnover / Total income 1786653000 1786653000
2 Total Expenditure 1637280000 1637280000
3 Net Profit/(Loss) 59306000 59306000
4 Earnings Per Share 3.25 3.25
5 Total Assets 1679345000 1679345000
6 Total Liabilities 1679345000 1679345000
7 Net Worth 1054690000 1054690000


Standalone Audit qualification
Sr. Details of Audit Qualification Type of Audit Qualification Frequency of qualification For Audit Qualification(s) where the impact is quantified by the auditor For Audit Qualification(s) where the impact is not quantified by the auditor
Management's Views (i) Management's estimation on the impact of audit qualification (ii) If management is unable to estimate the impact, reasons for the same Auditors' Comments on (i) or (ii) above
1 Textual Information(1) Qualified opinion Repetitive Textual Information(2) Textual Information(3) Textual Information(4) Textual Information(5)


Text Block
Textual Information(1) The Company has booked insurance claim receivable amounting to Rs. 2,503.73 lakhs as on 31 March, 2024 out of which Rs. 618.48 Lakhs has been booked as loss during the financial year 2024-25. We are unable to comment on appropriateness of assumption taken for booking of insurance claim which is still under process with the insurance company and consequential impact, if any that may arise from this matter. (Refer Note 7 of the Statement). nWe conducted our audit in accordance with the Standards on Auditing (SAs) specified under section 143(10) of the Act and other pronouncements issued by the Institute of Chartered Accountants of India (the ICAI). Our responsibilities under those standards are further described in the Auditors Responsibilities for the Audit of the Standalone Annual Financial Results section of our report. We are independent of the Company, in accordance with the Code of Ethics issued by the ICAI together with the ethical requirements that are relevant to our audit of the financial statements under the provisions of the Act, and the Rules thereunder, and we have fulfilled our other ethical responsibilities in accordance with these requirements and the Code of Ethics. We believe that the audit evidence obtained by us is sufficient and appropriate to provide a basis for our opinion. n
Textual Information(2) NA
Textual Information(3) NA
Textual Information(4) Since the survey report from the insurance company is pending management is unable to estimate the impact of same on the financial statements of the company.
Textual Information(5) The Company has booked insurance claim receivable amounting to Rs. 2,503.73 lakhs as on 31 March, 2024 out of which Rs. 618.48 Lakhs has been booked as loss during the financial year 2024-25. We are unable to comment on appropriateness of assumption taken for booking of insurance claim which is still under process with the insurance company and consequential impact, if any that may arise from this matter.


Signatories details

Name of CEO / Managing director AVNISH BANSAL
Name of CFO ANILKUMAR SINGHANIA
Name of audit committee chairman MUKESH VYAS
Name of statutory auditor MAHESH C. SOLANKI & CO.
Name of other signatory, if any, with designation NA
Place Pithampur
Date 29-May-2025


Signatory Details
Name of signatory
Designation of person
Place
Date


Format for Disclosure of Related Party Transactions (applicable only for half-yearly filings i.e., 2nd and 4th quarter)
Sr No. Additional disclosure of related party transactions - applicable only in case the related party transaction relates to loans, inter-corporate deposits, advances or investments made or given by the listed entity/subsidiary. These details need to be disclosed only once, during the reporting period when such transaction was undertaken.
Details of the party (listed entity /subsidiary) entering into the transaction Details of the counterparty Type of related party transaction Details of other related party transaction Value of the related party transaction as approved by the audit committee Remarks on approval by audit committee Value of the related party transaction ratified by the audit committee Date of Audit Committee Meeting where the ratification was approved Value of transaction during the reporting period In case monies are due to either party as a result of the transaction In case any financial indebtedness is incurred to make or give loans, inter-corporate deposits, advances or investments Details of the loans, inter-corporate deposits, advances or investments Notes
Name PAN Name PAN Relationship of the counterparty with the listed entity or its subsidiary Opening balance Closing balance Nature of indebtedness (loan/ issuance of debt/ any other etc.) Details of other indebtedness Cost Tenure Nature (loan/ advance/ intercorporate deposit/ investment ) Interest Rate (%) Tenure Secured/ unsecured Purpose for which the funds will be utilised by the ultimate recipient of funds (endusage)
1 MOHINI HEALTH & HYGIENE LIMITED Avnish Bansal PROMOTER,MD Remuneration 8400000 excludes other perquisites approved by shareholder 0 2025-05-29 4200000 1189000 185000 Textual Information(1)
2 MOHINI HEALTH & HYGIENE LIMITED Sarvapriya Bansal Promoter, Wholetime Director Remuneration 8400000 excludes other perquisites approved by shareholder 0 2025-05-29 4200000 979000 409000 Textual Information(2)
3 MOHINI HEALTH & HYGIENE LIMITED Parul Bansal Wholetime Director Remuneration 8400000 excludes other perquisites approved by shareholder 0 2025-05-29 4200000 489000 448000 Textual Information(3)
4 MOHINI HEALTH & HYGIENE LIMITED Viral Patel Executive Director Remuneration 4200000 excludes other perquisites approved by shareholder 0 2025-05-29 2100000 1401000 2768000 Textual Information(4)
5 MOHINI HEALTH & HYGIENE LIMITED Supriya Bansal Daughter of Mr. Sarvapriya Bansal whole timeDirector Remuneration 2400000 NA 0 2025-05-29 747000 112000 112000 Textual Information(5)
6 MOHINI HEALTH & HYGIENE LIMITED Subhash Kumar Khandeliya. Son in law of Mr. Sarvapriya Bansal Remuneration 2400000 NA 0 2025-05-29 750000 113000 111000 Textual Information(6)
7 MOHINI HEALTH & HYGIENE LIMITED Arnika Jain Company Secretary, KMP Remuneration 600000 NA 0 2025-05-29 225000 38000 38000 Textual Information(7)
8 MOHINI HEALTH & HYGIENE LIMITED Anil Kumar Singhania CFO, KMP Remuneration 600000 NA 0 2025-05-29 300000 50000 50000 Textual Information(8)
9 MOHINI HEALTH & HYGIENE LIMITED Omavi Ventures Pvt. Ltd Director holding more than 20% Purchase of goods or services 200000000 Over all limits approved is 20 crores from Shareholders 0 2025-05-29 50000 143000 195000 Textual Information(9)
10 MOHINI HEALTH & HYGIENE LIMITED Vedant Kotton Pvt. Ltd Director holding more than 20% Any other transaction Expenses paid 469000 Overall limits approved by Shareholders is 25 crores for all transaction. 0 2025-05-29 469000 0 0 Textual Information(10)
11 MOHINI HEALTH & HYGIENE LIMITED Vedant Kotton Pvt. Ltd Director holding more than 20% Any other transaction job work 3646000 Maximum limits approved by Audit Committee & Shareholders is 25 crores for all transaction. 0 2025-05-29 3646000 0 0 Textual Information(11)
12 MOHINI HEALTH & HYGIENE LIMITED Vedant Kotton Pvt. Ltd Director holding more than 20% Sale of goods or services 36034000 Maximum limits approved by Audit Committee & Shareholders is 25 crores for all transaction. 0 2025-05-29 36034000 0 0 Textual Information(12)
13 MOHINI HEALTH & HYGIENE LIMITED Vedant Kotton Pvt. Ltd Director holding more than 20% Any other transaction Rent received 30000 Maximum limits approved by Audit Committee & Shareholders is 25 crores for all transaction. 0 2025-05-29 30000 0 0 Textual Information(13)
14 MOHINI HEALTH & HYGIENE LIMITED Vedant Kotton Pvt. Ltd Director holding more than 20% Purchase of goods or services 40682000 Maximum limits approved by Audit Committee & Shareholders is 25 crores for all transaction. 0 2025-05-29 40682000 45949000 59295000 Textual Information(14)
15 MOHINI HEALTH & HYGIENE LIMITED Vedant Kotton Pvt. Ltd Director holding more than 20% Loan 14750000 Maximum limits approved by Audit Committee & Shareholders is 25 crores for all transaction. 0 2025-05-29 14750000 14750000 0 Textual Information(15)
16 MOHINI HEALTH & HYGIENE LIMITED Mohini Hygiene Care Product Pvt. Ltd. Associate company Any other transaction Rent received 33000 Maximum limits approved by Audit Committee & Shareholders is 25 crores for all transaction. 0 2025-05-29 33000 0 0 Textual Information(16)
17 MOHINI HEALTH & HYGIENE LIMITED Anviti Health Care Pvt Ltd Director holding more than 20% Any other transaction Rent received 60000 Maximum limits approved by Audit Committee & Shareholders is 20 crores for all transaction. 0 2025-05-29 30000 0 0 Textual Information(17)
18 MOHINI HEALTH & HYGIENE LIMITED MOHINI EMPLOYEE WELFARE TRUST EMPLOYEE WELFARE TRUST Loan 3200000 Approved by the Shareholders 0 2025-05-29 3200000 0 0 Any other NA 0 NA Loan 0 on demand Unsecured share purchase Textual Information(18)
19 MOHINI HEALTH & HYGIENE LIMITED Mohini Active Life Pvt Ltd Wholly owned subsidiary Any other transaction Rent received 60000 maximum limits approved is 100 crores 0 2025-05-29 30000 0 0 Textual Information(19)
20 MOHINI HEALTH & HYGIENE LIMITED Mohini Active Life Pvt Ltd Wholly owned subsidiary Advance 1000000000 maximum limits approved is 100 crores 0 2025-05-29 33000000 49092000 82094000 Advance 0 on demand Unsecured business purpose Textual Information(20)
21 MOHINI HEALTH & HYGIENE LIMITED Mohini Hygiene Care Product PVT LTD Associate company Interest received 1013000 12% interest is charged on the loan or advances or Inter corporate deposits. Agreegate transaction limit is 25 crores for all the transactions mention in section 188 0 2025-05-29 1013000 8439000 9452000 Any other NA 0 na Inter-corporate deposit 0.12 on demand Unsecured business purpose Textual Information(21)
Total value of transaction during the reporting period 149689000



Text Block
Textual Information(1) Omnibus apporval of related party transaction is taken in Audit Committee meeting held on 6th March,2024 & Noting is done on quarterly basis by Audit Committee.
Textual Information(2) Omnibus apporval of related party transaction is taken in Audit Committee meeting held on 6th March,2024 & Noting is done on quarterly basis by Audit Committee.
Textual Information(3) Omnibus apporval of related party transaction is taken in Audit Committee meeting held on 6th March,2024 & Noting is done on quarterly basis by Audit Committee.
Textual Information(4) Omnibus apporval of related party transaction is taken in Audit Committee meeting held on 6th March,2024 & Noting is done on quarterly basis by Audit Committee.
Textual Information(5) Omnibus apporval of related party transaction is taken in Audit Committee meeting held on 6th March,2024 & Noting is done on quarterly basis by Audit Committee.
Textual Information(6) Omnibus apporval of related party transaction is taken in Audit Committee meeting held on 6th March,2024 & Noting is done on quarterly basis by Audit Committee.
Textual Information(7) Omnibus apporval of related party transaction is taken in Audit Committee meeting held on 6th March,2024 & Noting is done on quarterly basis by Audit Committee.
Textual Information(8) Omnibus apporval of related party transaction is taken in Audit Committee meeting held on 6th March,2024 & Noting is done on quarterly basis by Audit Committee.
Textual Information(9) Omnibus apporval of related party transaction is taken in Audit Committee meeting held on 6th March,2024 & Noting is done on quarterly basis by Audit Committee.
Textual Information(10) Omnibus apporval of related party transaction is taken in Audit Committee meeting held on 6th March,2024 & Noting is done on quarterly basis by Audit Committee.
Textual Information(11) Omnibus apporval of related party transaction is taken in Audit Committee meeting held on 6th March,2024 & Noting is done on quarterly basis by Audit Committee.
Textual Information(12) Omnibus apporval of related party transaction is taken in Audit Committee meeting held on 6th March,2024 & Noting is done on quarterly basis by Audit Committee.
Textual Information(13) Omnibus apporval of related party transaction is taken in Audit Committee meeting held on 6th March,2024 & Noting is done on quarterly basis by Audit Committee.
Textual Information(14) Omnibus apporval of related party transaction is taken in Audit Committee meeting held on 6th March,2024 & Noting is done on quarterly basis by Audit Committee.
Textual Information(15) Omnibus apporval of related party transaction is taken in Audit Committee meeting held on 6th March,2024 & Noting is done on quarterly basis by Audit Committee.
Textual Information(16) Omnibus apporval of related party transaction is taken in Audit Committee meeting held on 6th March,2024 & Noting is done on quarterly basis by Audit Committee.
Textual Information(17) Omnibus apporval of related party transaction is taken in Audit Committee meeting held on 6th March,2024 & Noting is done on quarterly basis by Audit Committee.
Textual Information(18) Omnibus apporval of related party transaction is taken in Audit Committee meeting held on 6th March,2024 & Noting is done on quarterly basis by Audit Committee.
Textual Information(19) Omnibus apporval of related party transaction is taken in Audit Committee meeting held on 6th March,2024 & Noting is done on quarterly basis by Audit Committee.
Textual Information(20) Omnibus apporval of related party transaction is taken in Audit Committee meeting held on 6th March,2024 & Noting is done on quarterly basis by Audit Committee.
Textual Information(21) Omnibus apporval of related party transaction is taken in Audit Committee meeting held on 6th March,2024 & Noting is done on quarterly basis by Audit Committee.